2017 Parkinson Study Group Symposium and Training

2017年帕金森研究组研讨会及培训

• 批准号: 9398499
• 负责人: MICHAEL A SCHWARZSCHILD
• 金额: $ 2.5万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-07-01 至 2018-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9398499
• 关键词: Advocate; Alzheimer' s Disease; Ataxia; Clinical; Clinical Investigator; Clinical Research; Clinical Trials; Collaborations; Development; Disease; Dystonia; Education; Educational Activities; Educational workshop; Ensure; Etiology; Fostering; Foundations; Future; Gilles de la Tourette syndrome; Goals; Huntington Disease; Immunotherapeutic agent; Immunotherapy; Investments; Knowledge; Learning; Mentors; Modification; Movement Disorders; Neurobiology; Neurodegenerative Disorders; Neurology; Parkinson Disease; Pathogenesis; Patient Care; Patients; Peer Review; Pharmacology; Program Reviews; Research; Research Activity; Research Methodology; Research Personnel; Research Project Grants; Research Proposals; Scientist; Therapeutic; Training; Training and Education; Translational Research; Tremor; career; career development; design; drug development; experience; genetic epidemiology; improved; insight; meetings; mobile computing; nervous system disorder; neuroimaging; novel; novel therapeutics; patient oriented; posters; programs; research study; skills; symposium; tool

Abstract The proposed conference project, centered on the annual clinical research symposium of the Parkinson Study Group (PSG) and associated annual meeting activities, will foster the education and training of early stage investigators to ensure that the highest quality translational and clinical research continues to be conducted toward improved therapy for Parkinson's and related neurological disease. This project goal will be achieved through two specific aims (SAs). In SA #1, the PSG will present the “31st Annual Symposium on the Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders” in collaboration with the Huntington Study Group (HSG), Dystonia Study Group (DSG), Tourette Syndrome Study Group (TSSG), Cooperative Ataxia Group (CAG), and Tremor Research Group (TRG) on Monday, September 17, 2017 in Fort Myers, FL. The peer-reviewed program includes both platform and poster presentations in a live format with audience participation. The symposium will focus on the emergence of immuno-therapy as a promising strategy for disease modification in Parkinson's and other neurodegenerative diseases, with keynote talks conveying complementary neurobiological, drug development, regulatory and patient perspectives. SA #2 is designed to provide early-stage clinical investigators with movement disorders training a multi-faceted practical orientation to PD clinical research. The selected junior investigators will participate in several novel and interactive, educational research activities in addition to the symposium, including a) direct exchange with experienced patient advocates of the Parkinson's Disease Foundation's PAIR (Parkinson's Advocates in Research) program to learn how patient input can benefit their research, and b) the PSG Mentoring Committee's junior investigator workshop on novel research methodologies. Junior investigators completing participation in the project will be substantially better prepared and motivated to pursue careers and studies in clinical neurology.

摘要 拟议的会议项目，以年度临床研究研讨会为中心， 帕金森研究小组（PSG）和相关的年会活动，将促进 教育和培训早期研究人员，以确保最高质量的翻译 临床研究继续朝着改善帕金森病的治疗方法进行， 相关的神经系统疾病。该项目目标将通过两个具体目标（SA）来实现。 在SA #1中，PSG将举办“第31届病因学、发病机制和 帕金森氏症和其他运动障碍的治疗”与 亨廷顿研究组（HSG）、肌张力障碍研究组（DSG）、抽动秽语综合征研究组 （TSSG），合作共济失调组（CAG），震颤研究组（TRG）周一， 2017年9月17日在佛罗里达州迈尔斯堡。同行评审的计划包括平台和 现场展示海报，观众参与。研讨会将重点讨论 免疫治疗作为一种有前途的疾病修饰策略的出现， 帕金森氏症和其他神经退行性疾病，主题演讲传达了 互补的神经生物学、药物开发、监管和患者观点。SA #2 旨在为早期临床研究人员提供运动障碍培训， 多方面的实践导向PD临床研究。被选中的初级调查员将 参加一些新颖的和互动的，教育研究活动，除了 研讨会，包括a）与有经验的帕金森病患者的直接交流 疾病基金会的PAIR（帕金森病研究倡导者）计划，以了解患者如何 输入可以使他们的研究受益，以及B）PSG指导委员会的初级研究员 关于新的研究方法的讲习班。初级研究者完成参与 项目将大大更好地准备和动机，追求职业和研究， 临床神经病学